TODD STRATEGY GROUP

Lobbying for ILLUMINA, INC. · Biotechnology company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $80,000.00 income · posted Jul 20, 2026

Lobbying activity 3

Trade (domestic/foreign)

General trade issues.

Health Issues

General discussions related to FDA regulation of diagnostics.

Medicare/Medicaid

General discussions related to Medicare reimbursement for diagnostic tests.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.